Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Pulmonary Hypertension, April 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 156 articles: HTML format

Single Articles

1. ZHU Y, Yang X, Cao X, Liu K, et al
   From nanotechnology to immunomodulation: emerging strategies targeting macrophages in high altitude pulmonary hypertension.
   J Nanobiotechnology. 2026 Apr 3. doi: 10.1186/s12951-026-04317.
   PubMed    
   Abstract available
   
   

2. BAK BM, Kauss ML, Teixeira MT, Sharpe EE, et al
   Neuraxial anesthesia for surgical pregnancy termination in patients with severe pulmonary hypertension: a case series (2019-2025).
   Int J Obstet Anesth. 2026;67:104886.
   PubMed    
   Abstract available
   
   

3. TIAN Y, Huang CL, Zhou H, Wang WD, et al
   A Novel Quantification Method for Ventricular Septal Curvature in Pulmonary Hypertension Associated With Left Heart Disease.
   Echocardiography. 2026;43:e70436.
   PubMed    
   Abstract available
   
   

4. HURTADO RENDON IS, Aslam R, Attaran R
   Non-Healing Venous Ulcer Associated With the Triple Threat of Deep Vein Reflux, Tricuspid Valve Regurgitation, and Pulmonary Hypertension.
   J Endovasc Ther. 2026 Apr 3:15266028261436748. doi: 10.1177/15266028261436748.
   PubMed    
   Abstract available
   
   

5. ZHANG J, Yan H, Wang Y, Dai Y, et al
   PAK5 drives vascular remodeling in hypoxic pulmonary hypertension via Drp1-dependent mitochondrial midzone division.
   Sci Rep. 2026 Apr 2. doi: 10.1038/s41598-026-46809.
   PubMed    
   
   
   

6. DRUMMOND R, Forbess L, Lankford A
   Group 5 Pulmonary Hypertension Resulting From Thyrotoxicosis During Pregnancy.
   JACC Case Rep. 2026;31:106656.
   PubMed    
   Abstract available
   
   

7. ZHAO L, Pang X
   Synergistic Cardiopulmonary Protection of Endothelin Receptor Antagonists Combined With Soluble Guanylate Cyclase Agonists in High-Risk Coronary Syndrome With Pulmonary Hypertension.
   Rev Cardiovasc Med. 2026;27:46401.
   PubMed    
   Abstract available
   
   

8. SUN Y
   The preoperative risks of pulmonary hypertension crisis for the cesarean puerpera with pulmonary artery hypertension.
   BMC Pregnancy Childbirth. 2026 Apr 1. doi: 10.1186/s12884-026-08736.
   PubMed    
   
   
   

9. MORISHITA K, Ishii S, Maki H, Hatano M, et al
   Utility of Acute Vasodilator Challenge with Inhaled Nitric Oxide to Predict Pulmonary Hemodynamic Reversibility in Patients with Pulmonary Hypertension due to Left Heart Disease Referred for Heart Transplantation.
   Int Heart J. 2026;67:150-155.
   PubMed    
   Abstract available
   
   

10. ZHENG S, Li Y, Liu Z, Chen Y, et al
    Pulmonary hypertension in Takayasu arteritis with pulmonary artery involvement: risk factors and impact on mortality.
    BMJ Open Respir Res. 2026;13:e003854.
    PubMed    
    Abstract available
    
    

11. ITURRIAGAGOITIA A, Bove T, De Pauw M, Vandecasteele E, et al
    Tricuspid Regurgitation Peak-to-Mean Velocity Ratio: Linking Doppler Morphology to Right Heart Hemodynamics in Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2026 Mar 30:S0894-7317(26)00132.
    PubMed    
    Abstract available
    
    

12. CHEN Y, Liu M, Liu J, Chen S, et al
    Elevated pulmonary vascular resistance is associated with acute exacerbation admission in patients with chronic obstructive pulmonary disease-related pulmonary hypertension.
    Respir Med. 2026 Mar 30:108801. doi: 10.1016/j.rmed.2026.108801.
    PubMed    
    Abstract available
    
    

13. EROL C
    Selexipag for Pulmonary Hypertension, TAVI and more.
    Anatol J Cardiol. 2026;30:212.
    PubMed    
    
    
    

14. ZHANG Z, Shi Y, Liu Y, Cao Y, et al
    Echocardiographic Evaluation of Global Cardiac Function in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: An Integrated Review of Parameters and Techniques.
    Echocardiography. 2026;43:e70442.
    PubMed    
    Abstract available
    
    

15. CAO Y, Dong W, Shi Y, Sun X, et al
    Conceptual Reconsideration of the Classification of Pulmonary Hypertension: From 5 Groups to 2 Groups.
    JACC Asia. 2026 Mar 23:S2772-3747(26)00112-2. doi: 10.1016/j.jacasi.2026.
    PubMed    
    Abstract available
    
    

16. KATZ JB, Chen K, Cuttica MJ, Mylvaganam R, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Identifying and Managing Complications for the Operator.
    J Soc Cardiovasc Angiogr Interv. 2025;5:104049.
    PubMed    
    Abstract available
    
    

17. JURTH T, Marasco S
    Chronic Thromboembolic Pulmonary Hypertension: A Narrative Review.
    Cureus. 2026;18:e104418.
    PubMed    
    Abstract available
    
    

18. SINGH N, DuBrock HM, Prisco SZ, Dai Z, et al
    The Importance of Liver-Lung Communication in Pulmonary Vascular Diseases.
    Compr Physiol. 2026;16:e70140.
    PubMed    
    Abstract available
    
    

19. PEREZ-RIERA AR, Barbosa-Barros R, da Silva Rocha M, da Silva Rocha CA, et al
    A child with a large ostium secundum atrial septal defect, pulmonary hypertension, and the characteristic Crochetage electro-vectorcardiographic pattern.
    J Electrocardiol. 2026;97:154238.
    PubMed    
    Abstract available
    
    

20. KRAMER T, Weis H, Kural M, Kramer M, et al
    Correlation of ventilation-perfusion mismatch with hemodynamics in chronic thromboembolic pulmonary hypertension: a quantitative V/Q SPECT analysis.
    Ann Am Thorac Soc. 2026;23:646-650.
    PubMed    
    
    
    

21. LIU X, Zheng X, Zhang Y, Fang Y, et al
    Complementary multi-omics profiling of chronic thromboembolic pulmonary hypertension reveals immune cell alterations, epigenetic changes, and genetically supported candidate genes.
    Animal Model Exp Med. 2026 Mar 31. doi: 10.1002/ame2.70166.
    PubMed    
    Abstract available
    
    

22. GAUDIO D, Piscione M, Pala B, De Mitri S, et al
    TAPSE/sPAP Ratio in Systemic Sclerosis: Evidence From Pulmonary Hypertension and Implications for Early Risk Stratification-A Systematic Review.
    Echocardiography. 2026;43:e70440.
    PubMed    
    Abstract available
    
    

23. SANTOSO YACE, Marsam RK, Anggrahini DW, Hartopo AB, et al
    Accuracy of Echocardiographic Parameters in Diagnosing Pulmonary Hypertension in Adult Patients With Uncorrected Secundum Atrial Septal Defect.
    Echocardiography. 2026;43:e70427.
    PubMed    
    Abstract available
    
    

24. YAO ZZ, Yu AZ, Feng X
    [A Meta analysis of risk factors for pulmonary hypertension related to bronchopulmonary dysplasia in preterm infants].
    Zhongguo Dang Dai Er Ke Za Zhi. 2026;28:293-300.
    PubMed    
    Abstract available
    
    

25. WU P, Zhong D, He X, Li Y, et al
    The Potential Role of Calcium Channels in Pulmonary Hypertension.
    Biomed Res Int. 2026;2026:e4121036.
    PubMed    
    Abstract available
    
    

26. LAI YJ, Huang YL, Tsai CY, Chen PR, et al
    TGF-beta-induced autophagy in pulmonary artery endothelial cells associated with chronic thromboembolic pulmonary hypertension.
    J Mol Med (Berl). 2026;104:57.
    PubMed    
    Abstract available
    
    

27. ISAAC MAXIMO LM, Assis de Carlos G, Messias Hirano Padrao E, Beshish AG, et al
    Pulmonary Hypertension Association with mortality in Newborns with Giant Omphalocele: A Systematic Review and Meta-Analysis.
    Neonatology. 2026 Mar 30:1-19. doi: 10.1159/000551723.
    PubMed    
    Abstract available
    
    

28. FUMAGALLI RM, Zbinden S, Cardi S, Furbringer-Schwarz A, et al
    Post-pulmonary embolism cardiac impairment and chronic thromboembolic pulmonary hypertension after ultrasound-assisted catheter-directed thrombolysis for acute pulmonary embolism.
    Clin Res Cardiol. 2026 Mar 30. doi: 10.1007/s00392-026-02894.
    PubMed    
    Abstract available
    
    

29. ALI HR, Faiz SA, Deswal A, Palaskas N, et al
    Sotatercept for the Treatment of Myeloproliferative Neoplasm-Associated Group 5 Pulmonary Hypertension.
    JACC CardioOncol. 2026 Mar 20:S2666-0873(26)00050.
    PubMed    
    
    
    

30. STAVRI A, Krasnow M, Schober KE
    Echocardiographic evaluation of pulmonary vascular resistance in 459 dogs with Doppler-derived pulmonary hypertension.
    J Vet Intern Med. 2026;40:aalag051.
    PubMed    
    Abstract available
    
    

31. CORSI D, Mousa A, Patel D, Albert C, et al
    Multimodality imaging of patent ductus arteriosus with severe pulmonary hypertension following 3 pregnancies.
    Radiol Case Rep. 2026;21:2467-2471.
    PubMed    
    Abstract available
    
    

32. ZHOU Y, Bai Y, Yang S, Wang S, et al
    Integrative elucidation of Panax notoginseng 's action against pulmonary hypertension: Network pharmacology and molecular docking insights.
    J Ethnopharmacol. 2026;365:121546.
    PubMed    
    Abstract available
    
    

33. KULA S
    Pulmo: Patient Education in Pulmonary Hypertension via Artificial Intelligence-Based Digital Characters.
    Turk Kardiyol Dern Ars. 2026 Mar 27. doi: 10.5543/tkda.2026.07902.
    PubMed    
    
    
    

34. GOEL K, Ormesher R, Pratte KA, Wang Y, et al
    Vascular-related proteomic signatures in COPD with suspected pulmonary hypertension as predictors of FEV(1) impairment.
    Respir Res. 2026 Mar 28. doi: 10.1186/s12931-026-03622.
    PubMed    
    
    
    

35. FANG X, He Y
    Hypoxic Pulmonary Hypertension: Molecular Mechanisms and Clinical Research Advances.
    Int J Mol Sci. 2026;27:2762.
    PubMed    
    Abstract available
    
    

36. SZARPAK L, Jach ME, Skoczylas M, Radej S, et al
    Clonal Hematopoiesis (CHIP) in Pulmonary Embolism and CTEPH: Evidence, Mechanisms, and Risk Stratification.
    Int J Mol Sci. 2026;27:2750.
    PubMed    
    Abstract available
    
    

37. CHEN X, Wang X, Xu R, Gao S, et al
    Beyond the Vasculature: The Emerging Role of Systemic Metabolism and Immunometabolism in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:2571.
    PubMed    
    Abstract available
    
    

38. ARTEMIEVA M, Kozaeva L, Kuropatkina T, Gufranov K, et al
    Molecular Hydrogen Modulates the Baroreflex Activity and Reduces the Vascular Adrenoreceptor Sensitivity to Phenylephrine and Lung Inflammation in Rats with Pulmonary Hypertension.
    Biomedicines. 2026;14:494.
    PubMed    
    Abstract available
    
    

39. YI L, He W, He C, Shi X, et al
    ALDOB K87 lactylation drives mitochondrial fission and metabolic reprogramming in pulmonary hypertension.
    Commun Biol. 2026 Mar 27. doi: 10.1038/s42003-026-09934.
    PubMed    
    Abstract available
    
    

40. CHIU K, Parikh T, Pierce Reitnauer J, Khan SA, et al
    The impact of pulmonary hypertension and comorbidities on in-hospital mortality in hypertrophic obstructive cardiomyopathy: A nationwide analysis from 2016 to 2021.
    Heart Lung. 2026;78:102758.
    PubMed    
    Abstract available
    
    

41. KOVACS-KASA A, Annex BH
    Pulmonary Endothelium: A Driver and Therapeutic Target in Pulmonary Hypertension.
    JACC Basic Transl Sci. 2026;11:101528.
    PubMed    
    
    
    

42. GENECAND L, Boucly A, Sitbon O, Montani D, et al
    Does the Method Matter? Direct Fick Versus Thermodilution in the Haemodynamic Assessment of Pulmonary Hypertension.
    ESC Heart Fail. 2026 Mar 27:xvag093. doi: 10.1093.
    PubMed    
    
    
    

43. KYLE AR, Jose A, Catherman K, Elwing J, et al
    Real-World Outcomes of Inhaled Treprostinil in Pulmonary Hypertension Related to Interstitial Lung Disease: A Multicenter, Retrospective Analysis.
    J Cardiovasc Dev Dis. 2026;13:129.
    PubMed    
    Abstract available
    
    

44. OZGUN S, Sari G, Koyuncu A, Ezber R, et al
    Impact of pulmonary hypertension on mortality in progressive massive fibrosis.
    Sarcoidosis Vasc Diffuse Lung Dis. 2026;43:18391.
    PubMed    
    Abstract available
    
    

45. CHEN H, Chen J, Hou C, Rui H, et al
    Identification of Novel Drug Targets for Pulmonary Arterial Hypertension through Integrated Plasma Proteomics.
    J Proteome Res. 2026;25:2123-2134.
    PubMed    
    Abstract available
    
    

46. PILKA M, Darocha S, Waligora M, Kopec G, et al
    The prevalence and long-term response to calcium channel blockers in patients with pulmonary arterial hypertension and positive vasoreactivity test - results of multicenter national registry (BNP-PL).
    Orphanet J Rare Dis. 2026;21:119.
    PubMed    
    Abstract available
    
    

47. DAI C, Li X, Chu TS, Wan YP, et al
    Neutrophil-mediated delivery of curcumin-loaded manganese-doped zeolitic imidazolate framework-8 nanozymes for pulmonary arterial hypertension.
    J Nanobiotechnology. 2026;24:292.
    PubMed    
    Abstract available
    
    

48. TORUN EG, Dogan O, Bagrul D, Ece I, et al
    Individualised interventional strategies and clinical outcomes in paediatric patients with pulmonary arterial hypertension.
    Cardiol Young. 2026;36:294-305.
    PubMed    
    Abstract available
    
    

49. RODRIGUEZ JO, Shumway D, Tubbs P, Leek M, et al
    High-Altitude Pulmonary Edema Management in a Special Operator.
    J Spec Oper Med. 2026;26:93-0.
    PubMed    
    Abstract available
    
    

50. WACKER J, Joye R, Beghetti M
    Treatment options for children with pulmonary arterial hypertension associated with congenital heart disease.
    Expert Rev Respir Med. 2026;20:369-377.
    PubMed    
    Abstract available
    
    

51. COUCH TJ, Beck GJ, Berman-Rosenzweig E, Carr JJ, et al
    Pulmonary artery size on computed tomography associates with mean pulmonary artery pressure and mortality.
    Ann Am Thorac Soc. 2026;23:494-505.
    PubMed    
    Abstract available
    
    

52. HU R, Bai J, Pan Y, Liu D, et al
    Salusin-alpha Restores Vascular Relaxation and Remodeling in Pulmonary Hypertension.
    Hypertension. 2026 Apr 10. doi: 10.1161/HYPERTENSIONAHA.125.25722.
    PubMed    
    Abstract available
    
    

53. SMITH M, Grice J, O'Leary J, Smith GT, et al
    Comparison of Lung Perfusion Using X-Ray Pulsatility Index With Pulmonary Angiography in Chronic Thromboembolic Pulmonary Hypertension.
    J Thorac Imaging. 2026 Apr 10. doi: 10.1097/RTI.0000000000000885.
    PubMed    
    Abstract available
    
    

54. DING CW, Qiu JY, Shen H, Yan Y, et al
    Emerging significance of E3 ubiquitin ligases and Deubiquitinases in pulmonary hypertension.
    Mol Med. 2026 Apr 9. doi: 10.1186/s10020-026-01478.
    PubMed    
    
    
    

55. SCELSI L, Badagliacca R, Vicenzi M, Di Poi E, et al
    Understanding the burden of pulmonary arterial hypertension among patients and caregivers through narrative medicine: data from Italian multicentre observational INSPECTIO study.
    BMJ Open Respir Res. 2026;13:e003377.
    PubMed    
    Abstract available
    
    

56. NOFAL SM, El-Mashad AM, Elmesiry AM, Abouelenain AM, et al
    Melatonin effects on the left ventricular function in neonates with persistent pulmonary hypertension.
    Eur J Pediatr. 2026;185:247.
    PubMed    
    Abstract available
    
    

57. WEBER MP, Ahmad D, Eisen HJ, Storozynsky E, et al
    Utility of Right Ventricular Mass Ratios in Recipients With Pulmonary Hypertension: A United Network for Organ-Sharing Database Analysis.
    Clin Transplant. 2026;40:e70505.
    PubMed    
    Abstract available
    
    

58. ABBAY A, Askanbekova A, Semenova Y, Kuzhakhmetova A, et al
    Clinical characteristics, management strategies, and survival outcomes of patients with chronic thromboembolic pulmonary hypertension in Central Asia: experience from the sole pulmonary endarterectomy center.
    Front Cardiovasc Med. 2026;13:1786958.
    PubMed    
    Abstract available
    
    

59. WEI X, Shi W, Dong X, Kong W, et al
    Hypobaric hypoxia can lead to an increase in lung dendritic cells and promote T-cell immunosuppression, thereby preventing the excessive progression of high-altitude pulmonary edema.
    Front Immunol. 2026;17:1752864.
    PubMed    
    Abstract available
    
    

60. WANG Y, Wu J, Ma Q, Chen H, et al
    Advances in Novel Therapeutic Strategies for Pulmonary Arterial Hypertension.
    Can Respir J. 2026;2026:e8046858.
    PubMed    
    Abstract available
    
    

61. SIMPKIN CT, DeLima M, MacBeth M, Burkett DA, et al
    Eccentricity Index Is Associated With Pulmonary Arterial Hypertension in Children After Repair of Complete Atrioventricular Septal Defects.
    Echocardiography. 2026;43:e70451.
    PubMed    
    Abstract available
    
    

62. HOMEDI A, Ali K, Alamer F, Mandurah A, et al
    Early targeted neonatal echocardiography identifies biventricular dysfunction and pulmonary hypertension associated with death or severe bronchopulmonary dysplasia in infants born before 29 weeks' gestation.
    Front Pediatr. 2026;14:1782985.
    PubMed    
    Abstract available
    
    

63. ZHAO A, Wu Z, Yao X, Jiang T, et al
    Extreme and moderate temperatures and risk of hospitalizations for pulmonary hypertension: an 11-year time-series study in Shanghai, China.
    Front Med (Lausanne). 2026;13:1771445.
    PubMed    
    Abstract available
    
    

64. NINGYOU H
    Beyond Awareness: Operationalizing PROMs to Address the Invisible Burden of Women's Health in Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70295.
    PubMed    
    
    
    

65. KIRUBAKARAN A, Gray K, Slater T, Cass-Tansey Z, et al
    Persistent pulmonary hypertension, neonatal stroke, coagulopathy and multi-organ failure due to severe enterovirus sepsis: two case reports.
    BMC Pediatr. 2026 Apr 7. doi: 10.1186/s12887-026-06812.
    PubMed    
    
    
    

66. DENG X, Zhu F, Guo Y, Zhang Q, et al
    A Pumilio-dependent post-transcriptional mechanism drives pulmonary hypertension via KCNK3 suppression.
    Biochim Biophys Acta Mol Basis Dis. 2026;1872:168243.
    PubMed    
    Abstract available
    
    

67. TRISTAN CD, Wijayanto MA, Kynaya EM, Budiono EA, et al
    Prevalence and Factors Associated With Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Meta-Analysis and Meta-Regression.
    Cardiol Rev. 2026 Apr 7. doi: 10.1097/CRD.0000000000001235.
    PubMed    
    Abstract available
    
    

68. TIAN H, Wu Q, Wang Z, Zhang Z, et al
    Enhancing Intermediate-Risk Stratification in Pulmonary Hypertension: CMR-Derived Quantification of Right Ventricular-Arterial Coupling.
    Acad Radiol. 2026 Apr 6:S1076-6332(26)00191-1. doi: 10.1016/j.acra.2026.
    PubMed    
    Abstract available
    
    

69. BOXHAMMER E, Hammerer M, Schorghofer N, Clodi N, et al
    Sex-specific utility of pulmonary artery metrics in predicting pulmonary hypertension and survival after TAVI: insights from advanced CT imaging.
    Insights Imaging. 2026;17:91.
    PubMed    
    Abstract available
    
    

70. NOVAK M, Kacar P, Poropat Flerin T, Prokselj K, et al
    Severe pulmonary hypertension as a diagnostic challenge: a case of congenitally corrected transposition of the great arteries with dextrocardia in an elderly patient.
    Cardiol Young. 2026 Apr 7:1-4. doi: 10.1017/S1047951126111925.
    PubMed    
    Abstract available
    
    

71. KATAYAMA Y, Hirata K, Nishimura Y, Nakahari A, et al
    Sildenafil for bronchopulmonary dysplasia-associated pulmonary hypertension: A systematic search and narrative synthesis.
    Pediatr Int. 2026;68:e70385.
    PubMed    
    Abstract available
    
    

72. DMUCHOWSKA DA
    The choroid as a vascular sensor in pulmonary hypertension: an oculomic mini review.
    Front Cardiovasc Med. 2026;13:1779239.
    PubMed    
    Abstract available
    
    

73. ISLAM MT, Karim T, Mony SA, Bhuyan MMR, et al
    Pulmonary Hypertension in Down Syndrome Versus Non-syndromic Pediatric Populations With Congenital Heart Disease: A Comparative Study.
    Cureus. 2026;18:e104634.
    PubMed    
    Abstract available
    
    

74. KANG JH, Yoon J, Song JJ, Choi HJ, et al
    Clinical, serological and haemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicentre retrospective study from Korea.
    Rheumatology (Oxford). 2026;65:keag148.
    PubMed    
    Abstract available
    
    

75. MEDZIKOVIC L, Ruffenach G, Dehghanitafti A, Wong B, et al
    Hepatocyte growth factor may contribute to male protection against pulmonary arterial hypertension.
    Biol Sex Differ. 2026;17:64.
    PubMed    
    Abstract available
    
    

76. OBLITAS CM, Barrera-Lopez L, Galeano-Valle F, Demelo-Rodriguez P, et al
    Post-pulmonary embolism syndrome: a practical narrative review.
    Rev Clin Esp (Barc). 2026;226:502497.
    PubMed    
    Abstract available
    
    

77. ELWING JM, Krishnan M, Parikh KS, Sargent T, et al
    Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review.
    Adv Ther. 2026;43:1384-1407.
    PubMed    
    Abstract available
    
    

78. GLANDORF J, Klein MM, Klimes F, Kern AL, et al
    Analysis of Pulsatile Vessel Expansion in Healthy, COPD-and PH-Patients Using Dynamic Vessel Segmentation in Free-Breathing Lung MRI.
    J Magn Reson Imaging. 2026 Jan 31. doi: 10.1002/jmri.70249.
    PubMed    
    Abstract available
    
    

79. CHANG GJ, Yeh YH, Chen WJ, Hsu SC, et al
    Caffeic Acid Phenethyl Ester Improves Right Ventricular Function and Reduces Arrhythmogenesis by Attenuating Structural and Electromechanical Remodeling in Pulmonary Arterial Hypertensive Rats.
    Phytother Res. 2026;40:1555-1576.
    PubMed    
    Abstract available
    
    

80. MITSUYOSHI K, Kubota K, Miyanaga S, Akao M, et al
    Association of peak expiratory flow rate with clinical outcomes in pulmonary arterial hypertension.
    Hypertens Res. 2026;49:1509-1516.
    PubMed    
    Abstract available
    
    

81. ZHANG Y, Bu F, Qi Y, Zhang D, et al
    Impedance Cardiography Is a Potent Non-Invasive Method in Cardiac Output Measurement and Pulmonary Arterial Hypertension Risk Assessment.
    Anatol J Cardiol. 2025;29:347-354.
    PubMed    
    Abstract available
    
    

82. YIN X, Li J, Luo Y, Li T, et al
    Dysregulation of miR-330-3p is Involved in the Occurrence and Development of Pulmonary Arterial Hypertension Caused by Congenital Heart Disease.
    Anatol J Cardiol. 2025;29:291-299.
    PubMed    
    Abstract available
    
    

83. VISSER LC, Johnson LR
    Pulmonary Hypertension.
    Vet Clin North Am Small Anim Pract. 2026 Apr 16:S0195-5616(26)00021.
    PubMed    
    Abstract available
    
    

84. O'LOUGHLIN C, Sirbu I
    Letter to the editor in response to: "Neuraxial anesthesia for surgical pregnancy termination in patients with severe pulmonary hypertension: a case series (2019-2025)".
    Int J Obstet Anesth. 2026;67:104942.
    PubMed    
    
    
    

85. PERINO J, Bassan P, Salvo F, Miremont-Salame G, et al
    Serious respiratory distress associated with bosentan administration in chronic thromboembolic pulmonary hypertension: A case report.
    Therapie. 2026 Mar 20:S0040-5957(26)00049-1. doi: 10.1016/j.therap.2026.
    PubMed    
    
    
    

86. SCHMALZING M, Moinzadeh P, Weliwitage J, Henes J, et al
    Treatment of systemic sclerosis-associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis.
    Rheumatology (Oxford). 2026 Apr 15:keag155. doi: 10.1093.
    PubMed    
    Abstract available
    
    

87. WU X, Cao Y, Jiao J, Fang J, et al
    Chromosome 17q23.1-q23.2 deletion syndrome with severe pulmonary hypertension in neonates: two case reports and literature review.
    BMC Pediatr. 2026 Apr 15. doi: 10.1186/s12887-026-06839.
    PubMed    
    
    
    

88. NAKAJIMA T, Ushijima R, Tanaka R
    Optimization of pulmonary blood flow analysis method using dynamic chest radiography.
    J Appl Clin Med Phys. 2026;27:e70588.
    PubMed    
    Abstract available
    
    

89. GREGORIETTI V, Lopez-Fernandez T, Herrmann J, Costa D, et al
    The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study.
    Cardiooncology. 2026 Apr 14. doi: 10.1186/s40959-026-00477.
    PubMed    
    
    
    

90. LEHMAN A, Ahmed S, Mohajeri A, Berezuk AM, et al
    Mutations in VCP cause Adams-Oliver syndrome with or without pulmonary hypertension.
    Genet Med. 2026 Apr 13:102579. doi: 10.1016/j.gim.2026.102579.
    PubMed    
    Abstract available
    
    

91. NEAGU A, Capusa C, Zugravu A, Croitoru EL, et al
    Prevalence and Predictors of Pulmonary Hypertension in End-Stage Renal Disease: a Single-Center Cross-Sectional Study.
    Maedica (Bucur). 2026;21:35-41.
    PubMed    
    Abstract available
    
    

92. TRACY MC, Collaco JM, Akangire G, Bamat NA, et al
    Outpatient Medication Prescribing Patterns in Bronchopulmonary Dysplasia: A Survey of Clinical Practices and Challenges.
    Pediatr Pulmonol. 2026;61:e71622.
    PubMed    
    Abstract available
    
    

93. ROGER Y, Sardine-Rama A, Bosacoma A, Gomez I, et al
    Understanding the Impact of Hypoxia on Pulmonary Artery Endothelial Cells in Chronic Thromboembolic Pulmonary Hypertension Patients.
    Int J Mol Sci. 2026;27:3207.
    PubMed    
    Abstract available
    
    

94. CEKIRDEKCI EI, Onar LC
    Clinical and Hemodynamic Effects of Pulmonary Artery Denervation in Pulmonary Hypertension Despite Optimized Pharmacotherapy: An Updated Systematic Review and Meta-Analysis.
    J Clin Med. 2026;15:2619.
    PubMed    
    Abstract available
    
    

95. FAROOQ T, Mohsin M, Fatima W, Ali D, et al
    Exercise testing for evaluating right ventricular (RV) function in pulmonary hypertension - A review.
    Lung India. 2026 Apr 13. doi: 10.4103.
    PubMed    
    Abstract available
    
    

96. SUCHANEK V, Jakubicek R, Hrdlicka J, Novak M, et al
    Automated attenuation analysis of CT pulmonary angiography identifies peripheral hyperperfusion as a prognostic marker in non-surgical chronic thromboembolic pulmonary hypertension (CTEPH).
    Quant Imaging Med Surg. 2026;16:265.
    PubMed    
    Abstract available
    
    

97. AGGARWAL MA, Merrill K, Yung D, Mark Grady R, et al
    Early Results of Sotatercept Treatment in Patients With Severe Pulmonary Hypertension and a Potts Shunt.
    Pulm Circ. 2026;16:e70296.
    PubMed    
    Abstract available
    
    

98. TIAN J, Gong S, Yuan P, Huang J, et al
    Metabolomic and lipidomic signatures associated with clinical improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Chin Med J Pulm Crit Care Med. 2026;4:92-94.
    PubMed    
    
    
    

99. TAI JYY, Hasdarngkul A, Khoo REY, Milner B, et al
    Diagnostic Performance of Magnetic Resonance Imaging in Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review.
    J Med Imaging Radiat Oncol. 2026 Apr 12. doi: 10.1111/1754-9485.70101.
    PubMed    
    Abstract available
    
    

100. HAGOG NATOUR H, Asaly A, Elgardt I, Natour A, et al
     Comparative Analysis of Clinical Features and Autoantibody Profiles in Systemic Sclerosis Patients Among Jewish and Arab Populations in Israel.
     Isr Med Assoc J. 2026;28:237-242.
     PubMed    
     Abstract available
     
     

101. JIN L, Jiang B, Wang X, Kong M, et al
     Mechanistic studies of molecular networks associated with pulmonary hypertension explored by combined transcriptome analysis of Project-methylation.
     Clin Epigenetics. 2026 Apr 11. doi: 10.1186/s13148-026-02075.
     PubMed    
     Abstract available
     
     

102. WU M, Song W, Guo X, Lu Z, et al
     Celiac disease increases the risk of pulmonary arterial hypertension: A multivariable Mendelian randomization and mediation analysis.
     Medicine (Baltimore). 2026;105:e48334.
     PubMed    
     Abstract available
     
     

103. STOLZ L, Kresoja KP, von Stein J, Fortmeier V, et al
     Applying the 2025 ESC/EACTS Recommendations for the Treatment of Severe Tricuspid Regurgitation to Real-World Practice.
     JACC Cardiovasc Interv. 2026;19:843-853.
     PubMed    
     Abstract available
     
     

104. ZHU Y, Tang W, Xu R, Cai X, et al
     Circ_0068481 promotes pulmonary arterial smooth muscle cell remodeling via PTEN degradation and PI3K/AKT signaling activation.
     Gene. 2026;996:150130.
     PubMed    
     Abstract available
     
     

105. PI H, Xia L, Rayner SG, Probstfield JL, et al
     Harnessing metabolomics and proteomics in a clinical trial for pulmonary arterial hypertension: insights from post-hoc analysis of the REHAB-PH trial.
     EBioMedicine. 2026;126:106191.
     PubMed    
     Abstract available
     
     

106. LAGO-DOCAMPO M, Iglesias-Lopez A, Vilarino C, Baloira A, et al
     A circulating MicroRNA signature for the diagnosis of pulmonary arterial hypertension and functional characterization of candidate miR-3168.
     Sci Rep. 2026;16:12157.
     PubMed    
     Abstract available
     
     

107. LI L, Chen G, Qiao N, Li J, et al
     Rare T-box variants in adult pulmonary arterial hypertension with congenital heart disease.
     J Appl Genet. 2026;67:365-371.
     PubMed    
     Abstract available
     
     

108. MOESKES MMV, Derlin T, Hunkemoller AM, Schafer-Prokop C, et al
     Photon-counting CT vs V/Q SPECT for lobar perfusion quantification in chronic thromboembolic pulmonary hypertension.
     Eur Radiol. 2026 Apr 24. doi: 10.1007/s00330-026-12547.
     PubMed    
     Abstract available
     
     

109. SUMITOMO NF, Ishii T, Uchida K, Hosokawa S, et al
     Mid-term prognosis and risk stratification in patients with post-operative pulmonary hypertension: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR).
     Am Heart J Plus. 2026;65:100784.
     PubMed    
     Abstract available
     
     

110. CHAN CC, Teixeira BL, Bautista A, Stinson MD, et al
     Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio Correlates With Early Outcomes After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension.
     Respirology. 2026 Apr 23. doi: 10.1002/resp.70255.
     PubMed    
     Abstract available
     
     

111. MOMBEINI H, Frank RC, Mukherjee M
     Under Pressure: Rethinking Pulmonary Hypertension Through Tricuspid Regurgitation Waveform Morphology.
     J Am Soc Echocardiogr. 2026 Apr 21:S0894-7317(26)00171.
     PubMed    
     
     
     

112. NIIJIMA R, Otani K, Kodama T, Fujioka Y, et al
     Minocycline inhibits endothelin-1-induced contraction in isolated pulmonary artery.
     J Pharmacol Sci. 2026;161:28-31.
     PubMed    
     Abstract available
     
     

113. SOOMRO NA, Altowairki RS, Ahmed RN, Kurdi WI, et al
     Refractory cardiac arrest during epidural anesthesia for caesarean section in a patient with supra-systemic pulmonary hypertension rescued by VA ECMO.
     Saudi J Anaesth. 2026;20:470-472.
     PubMed    
     Abstract available
     
     

114. RIOU M, Genecand L, Canuet M, Degot T, et al
     Inhaled treprostinil for pulmonary hypertension associated with interstitial lung disease: advances, challenges, and future directions.
     Expert Rev Respir Med. 2026 Apr 23:1-17. doi: 10.1080/17476348.2026.2661412.
     PubMed    
     Abstract available
     
     

115. BEHERA R, Zhou Y, Gerges PH, Fan J, et al
     FOSL2 regulates endothelial cell state and chromatin accessibility in systemic sclerosis pulmonary vascular remodeling.
     JCI Insight. 2026;11:e189107.
     PubMed    
     Abstract available
     
     

116. LU J, Liao H, Huang Z, Bao C, et al
     Upregulation of CXCL10/CXCR3 Axis Induced by Pulmonary Hemodynamic Stress Promotes Vascular Remodeling in Chronic Thromboembolic Pulmonary Hypertension.
     Hypertension. 2026 Apr 22. doi: 10.1161/HYPERTENSIONAHA.125.24619.
     PubMed    
     Abstract available
     
     

117. CHU Y, Yang J, Ye T, Yu F, et al
     Identification and functional analysis of NAD(+) metabolism-related gene NT5E in pulmonary hypertension.
     Front Genet. 2026;17:1787122.
     PubMed    
     Abstract available
     
     

118. TRINDADE MCRG, Bonifacio IL, Brassard P, Oliveira RKF, et al
     Unveiling orthostatic hypotension in precapillary pulmonary hypertension.
     ERJ Open Res. 2026;12:00689-2025.
     PubMed    
     Abstract available
     
     

119. FAHIM M, Eldawud D, Osei N, Bonnah G, et al
     Efficacy of Catheter Ablation in Atrial Fibrillation Patients With Pulmonary Hypertension.
     Pacing Clin Electrophysiol. 2026 Apr 21. doi: 10.1111/pace.70266.
     PubMed    
     Abstract available
     
     

120. TARRAS ES, Homer R, Singh I
     Pre-capillary Pulmonary Hypertension in a Patient with Interlobular Septal Thickening and Prominent Mediastinal Lymphadenopathy.
     Ann Am Thorac Soc. 2026 Apr 11:aaoag099. doi: 10.1093.
     PubMed    
     
     
     

121. HOJEN AA, Baddeley E, Lindegaard SF, Ingemann-Molden S, et al
     Capturing the late complications of venous thromboembolism.
     Res Pract Thromb Haemost. 2026;10:103420.
     PubMed    
     Abstract available
     
     

122. NASIR M, Ahmed M
     Clinical profile, survival outcomes, and predictors of mortality in neonates with persistent pulmonary hypertension: a follow-up study from Hawassa, Ethiopia.
     BMC Pediatr. 2026 Apr 20. doi: 10.1186/s12887-026-06904.
     PubMed    
     
     
     

123. ALI K, Nandunjappa M, Homedi A, Arattu Thodika FM, et al
     Early post-operative hemodynamic recovery in infants with congenital diaphragmatic hernia.
     Eur J Pediatr. 2026;185:281.
     PubMed    
     Abstract available
     
     

124. ALKHANI A, Bendahmash A, Arefi A, Alquayt M, et al
     Scimitar Syndrome and Pulmonary Hypertension in Pediatric Population: A Retrospective Analysis of the Prevalence, Clinical Characteristics, Risk Factors, and Outcomes.
     Pulm Circ. 2026;16:e70284.
     PubMed    
     Abstract available
     
     

125. RAWLINGS GH, Green JL, Rothman AMK, Barrell-Stark ASL, et al
     Clinical Utility of the PHQ-2 and GAD-2 in Pulmonary Hypertension.
     Pulm Circ. 2026;16:e70299.
     PubMed    
     Abstract available
     
     

126. HANSEN JV, Lyhne MD, Poulsen MW, Karout L, et al
     Dual-energy CT based scoring to estimate perfusion changes after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
     JHLT Open. 2026;12:100543.
     PubMed    
     Abstract available
     
     

127. ZHANG S, Ju G, Zhang J, Dong F, et al
     Sodium Houttuyfonate Alleviates Monocrotaline-induced Pulmonary Hypertension by Regulating Canonical Transient Receptor Potential Channel Proteins via CHIP.
     Eur J Pharmacol. 2026 Apr 17:178874. doi: 10.1016/j.ejphar.2026.178874.
     PubMed    
     Abstract available
     
     

128. BERKANE AW, Yahiaoui R, Methia N, Djami-Temim N, et al
     Genetic analysis and clinical phenotype of pulmonary arterial hypertension in an Algerian population.
     Ann Saudi Med. 2026;46:111-120.
     PubMed    
     Abstract available
     
     

129. SESE DGA, Argula RG
     Beneath the surface: a narrative review of multidimensional burdens and pathways to patient-centered care in PAH.
     Ther Adv Respir Dis. 2026;20:17534666261438211.
     PubMed    
     Abstract available
     
     

130. GE RX, Shi JZ, Guo BH, Zhang MJ, et al
     Subamnex Ameliorates Hypoxia-Induced Pulmonary Arterial Hypertension through Modulation of the STAT3/p-STAT3 Pathway.
     J Med Chem. 2026;69:8790-8806.
     PubMed    
     Abstract available
     
     

131. FAIZAH NN, Ryanto GRT, Kencana SMS, Suzuki Y, et al
     Activin A-Endothelin-1 Axis Governs Pulmonary Vascular Remodeling: Mechanistic Basis for Emerging Therapies in PAH.
     Arterioscler Thromb Vasc Biol. 2026;46:e323681.
     PubMed    
     Abstract available
     
     

132. SHANG ST, Ho WJ, Chen KH, Hsieh MJ, et al
     Low positive affect as a predictor of mortality in pulmonary arterial hypertension: A Taiwanese cohort study integrating psychological and clinical risk factors.
     Heart Lung. 2026;77:102729.
     PubMed    
     Abstract available
     
     

133. BAI AS, Sorensen GL, Sundaram AB, Chang W, et al
     The emerging role of integrin signaling in pulmonary vascular disease.
     Am J Physiol Lung Cell Mol Physiol. 2026;330:L476-L486.
     PubMed    
     Abstract available
     
     

134. SUN J, Geng Y, Liu P
     Elevated Pulmonary Arterial Wedge Pressure and Balloon Pulmonary Angioplasty Efficacy in Chronic Thromboembolic Pulmonary Hypertension.
     Chest. 2026;169:e149-e150.
     PubMed    
     
     
     

135. MINHAS J, Al-Naamani N
     From Provider Judgment to Patient Perspective: Rethinking Functional Class in Pulmonary Hypertension.
     Chest. 2026;169:870-872.
     PubMed    
     
     
     

136. KHAN SL, Psoter KJ, Lin CT, Balasubramanian A, et al
     Imaging-based Pulmonary Hypertension Phenotypes in Connective Tissue Disease-related Interstitial Lung Disease.
     Chest. 2026 Apr 8:S0012-3692(26)00440-X. doi: 10.1016/j.chest.2026.
     PubMed    
     Abstract available
     
     

137. CHACON-BARAHONA J, Chung SJ, Garry JD, Frantz R, et al
     Metabolomics of Right Ventricular Function in Pulmonary Hypertension.
     Circ Res. 2026 Apr 15. doi: 10.1161/CIRCRESAHA.125.327342.
     PubMed    
     Abstract available
     
     

138. FORBES LM, Cornwell WK
     Group 1 Pulmonary Hypertension With Elevated Pulmonary Artery Wedge Pressure: Characterizing A Complex Phenotype.
     Circulation. 2026;153:963-966.
     PubMed    
     
     
     

139. GOMBERG-MAITLAND M, Tedford RJ, Langleben D, Rosenkranz S, et al
     Sotatercept for Combined Post- and Pre-capillary Pulmonary Hypertension Associated With Heart Failure: Results from the Phase 2, Randomized, Placebo-Controlled CADENCE Study.
     Circulation. 2026 Mar 29. doi: 10.1161/CIRCULATIONAHA.126.079918.
     PubMed    
     Abstract available
     
     

140. JAMBON-BARBARA C, Suissa S, Dell'Aniello S, Hlavaty A, et al
     Second- and Third-Generation BCR-ABL Tyrosine Kinase Inhibitors and the Risk of Pulmonary Arterial Hypertension: A Prevalent New-User Design.
     Circulation. 2026 Feb 12. doi: 10.1161/CIRCULATIONAHA.125.077764.
     PubMed    
     Abstract available
     
     

141. MOKHLESI B, Hache-Marliere M, Bjork ST, Jain D, et al
     Impact of positive airway pressure therapy on pulmonary arterial pressures in obstructive sleep apnoea or obesity hypoventilation syndrome: a systematic review and meta-analysis.
     Eur Respir J. 2026;67:2501037.
     PubMed    
     Abstract available
     
     

142. MEHTA A, Singh J
     Early Surfactant Therapy in Refractory Idiopathic Persistent Pulmonary Hypertension of the Newborn.
     Indian J Pediatr. 2026 Apr 14. doi: 10.1007/s12098-026-06127.
     PubMed    
     
     
     

143. COSTANZA L, Stead TS, Joyce MF, Maslow M, et al
     Comparing Echocardiography and Right Heart Catheterization for Mortality Prediction in Pulmonary Hypertension.
     J Cardiothorac Vasc Anesth. 2026 Mar 7:S1053-0770(26)00208.
     PubMed    
     Abstract available
     
     

144. PAGEL PS, Hang D, Freed JK, Crystal GJ, et al
     Advances in Cardiovascular Pharmacotherapy: VII. Soluble Guanylate Cyclase Stimulators in Pulmonary Hypertension and Heart Failure.
     J Cardiothorac Vasc Anesth. 2026 Feb 25:S1053-0770(26)00176.
     PubMed    
     Abstract available
     
     

145. SOTO L, Lareau A, Ducharme MP, Elmi-Sarabi M, et al
     Combined Inhaled Pulmonary Vasodilators in Cardiac Surgery: A Scoping Review.
     J Cardiothorac Vasc Anesth. 2025 Dec 12:S1053-0770(25)01220.
     PubMed    
     Abstract available
     
     

146. WANG YQ, Deng QY, Zhang ZZ, Wang GL, et al
     Short-Term Effect of Levosimendan in Acute Right Heart Failure Caused by Pulmonary Hypertension: A Pilot Study.
     J Cardiovasc Pharmacol. 2026 Apr 8. doi: 10.1097/FJC.0000000000001824.
     PubMed    
     Abstract available
     
     

147. MIHAI A
     Bridging therapy and residual pulmonary hypertension in chronic thromboembolic pulmonary hypertension: Insights into disease heterogeneity.
     J Heart Lung Transplant. 2026 Apr 9:S1053-2498(26)01797.
     PubMed    
     
     
     

148. SWAN TT, Mutaawe S
     Comment on: The landscape of referrals for lung transplantation in pulmonary arterial hypertension: A report from the Pulmonary Hypertension Association Registry.
     J Heart Lung Transplant. 2026 Jan 19:S1053-2498(26)00006.
     PubMed    
     
     
     

149. PAGNONI G, Vicenzi A, Coppi F
     Bridging Therapy and Residual Pulmonary Hypertension After Pulmonary Endarterectomy: Unmet Needs in Evidence and Clinical Decision-Making.
     J Heart Lung Transplant. 2026 Apr 15:S1053-2498(26)01847.
     PubMed    
     
     
     

150. APPENZELLER P, Ghani H, Pepke-Zaba J
     Considerations on residual pulmonary hypertension after pulmonary endarterectomy - a multimodal approach.
     J Heart Lung Transplant. 2026 Apr 10:S1053-2498(26)01835.
     PubMed    
     
     
     

151. CHOSHI H, Sugimoto S, Tomida S, Hayashi T, et al
     Longitudinal spatial transcriptomics reveals the molecular dynamics of pulmonary artery remodeling in pulmonary arterial hypertension.
     J Heart Lung Transplant. 2026;45:849-854.
     PubMed    
     Abstract available
     
     

152. MCLAUGHLIN VV, Howard L, Elwing J, Fernandes CC, et al
     Evaluating oral selexipag in pulmonary arterial hypertension: Insights on survival, safety, and dosing patterns from the complete observation period of GRIPHON and its open-label extension.
     J Heart Lung Transplant. 2026;45:835-846.
     PubMed    
     Abstract available
     
     

153. KING TL, McNamara PJ, Bischoff AR
     Does inhaled nitric oxide treatment of pulmonary hypertension in extremely premature infants improve patient outcomes?
     J Perinatol. 2026 Apr 9. doi: 10.1038/s41372-026-02666.
     PubMed    
     
     
     

154. CHANDRA A, Rios DR, Dagle D, McNamara PJ, et al
     Non-invasive nitric oxide use for pulmonary hypertension and pulmonary vascular disease associated with bronchopulmonary dysplasia in preterm infants.
     J Perinatol. 2026 Apr 15. doi: 10.1038/s41372-026-02687.
     PubMed    
     
     
     

155. TAO L, Chuan Z, Zhou H
     Pulmonary venous modeling versus cardiopulmonary reality in group 2 pulmonary hypertension.
     J Thorac Cardiovasc Surg. 2026 Apr 1:S0022-5223(26)00176.
     PubMed    
     
     
     

156. DANTOING C, Bouzerar R, Bohbot Y, Mayeux I, et al
     Quantification of pulmonary arterial pressure with 4D flow cardiac MRI velocity mapping in patients with suspected pulmonary hypertension: Comparison with right heart catheterization.
     PLoS One. 2026;21:e0346600.
     PubMed    
     Abstract available